Di‐methylation of CD147 at Lys148 (CD147‐K148me2) mediated by the methyltransferase NSD2 is a common post‐translational modification in non‐small cell lung cancer (NSCLC), which values significantly in unsatisfactory survival outcomes among NSCLC sufferers. Here, NSD2 is linked to non-small cell lung carcinoma.